Pfizer to seek emergency approval for its COVID-19 vaccine
New York: Pfizer Friday announced that it is moving ahead with its request of asking the US regulators to allow emergency use of its Covid-19 vaccine, which has shown 95 per cent efficacy in a totality of two data sets released in the last 10...











































